50242-138 : Actemra 180 mg/ml Subcutaneous Injection, Solution


NDC: 50242-138
Labeler: Genentech, Inc.
Product Type: Human Prescription Drug
Drug Name:  Actemra
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA125472
Rev. Date: 


NDC Package Codes:

  • 50242-138-01: 1 SYRINGE, GLASS IN 1 BOX (50242‑138‑01) > .9 ML IN 1 SYRINGE, GLASS
  • 50242-138-86: 1 SYRINGE, GLASS IN 1 BOX (50242‑138‑86) > .9 ML IN 1 SYRINGE, GLASS

Active Ingredients:

  • Tocilizumab

Dosage Strength:

  • 180 mg/mL

Pharmaceutical Classes:

  • Interleukin 6 Receptor Antagonists [MoA]
  • Interleukin-6 Receptor Antagonist [EPC]

Related Products:

Based on records with the same trade name.
  • 50242-135 Actemra 20 mg/ml Intravenous Injection, Solution, Concentrate by Genentech, Inc.
  • 50242-136 Actemra 20 mg/ml Intravenous Injection, Solution, Concentrate by Genentech, Inc.
  • 50242-137 Actemra 20 mg/ml Intravenous Injection, Solution, Concentrate by Genentech, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50242-138 QR Code

< Prev: 50242-137Next: 50242-140 >

Related Discussions:

Swollen and tender legs from Actemra?
My wife has been on Actemra for about 6-7months now and her doctor says it's working, my wife disagrees. Due to her ... 5 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.